Verus Capital Partners’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $330K | Sell |
13,628
-2,789
| -17% | -$67.6K | 0.03% | 309 |
|
|
2025
Q1 | $416K | Sell |
16,417
-1,883
| -10% | -$47.7K | 0.04% | 259 |
|
|
2024
Q4 | $485K | Sell |
18,300
-1,749
| -9% | -$46.4K | 0.04% | 221 |
|
|
2024
Q3 | $580K | Sell |
20,049
-1,135
| -5% | -$32.8K | 0.05% | 188 |
|
|
2024
Q2 | $593K | Buy |
21,184
+5,165
| +32% | +$145K | 0.06% | 182 |
|
|
2024
Q1 | $445K | Buy |
16,019
+106
| +0.7% | +$2.94K | 0.05% | 205 |
|
|
2023
Q4 | $458K | Buy |
15,913
+1,373
| +9% | +$39.5K | 0.06% | 184 |
|
|
2023
Q3 | $482K | Sell |
14,540
-2,171
| -13% | -$72K | 0.07% | 165 |
|
|
2023
Q2 | $613K | Buy |
16,711
+1,388
| +9% | +$50.9K | 0.09% | 138 |
|
|
2023
Q1 | $625K | Sell |
15,323
-960
| -6% | -$39.2K | 0.1% | 129 |
|
|
2022
Q4 | $834K | Sell |
16,283
-524
| -3% | -$26.9K | 0.16% | 95 |
|
|
2022
Q3 | $736K | Buy |
16,807
+6,127
| +57% | +$268K | 0.14% | 105 |
|
|
2022
Q2 | $920K | Sell |
10,680
-7,718
| -42% | -$665K | 0.18% | 98 |
|
|
2022
Q1 | $912K | Buy |
+18,398
| New | +$912K | 0.14% | 108 |
|
|
2020
Q1 | $633K | Buy |
20,439
+1,274
| +7% | +$39.5K | 0.2% | 70 |
|
|
2019
Q4 | $712K | Buy |
+19,165
| New | +$712K | 0.23% | 72 |
|